NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

483 hedge funds and large institutions have $9.2B invested in Neurocrine Biosciences in 2023 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 198 increasing their positions, 163 reducing their positions, and 86 closing their positions.

Holders
483
Holders Change
-43
Holders Change %
-8.17%
% of All Funds
7.73%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.11%
New
57
Increased
198
Reduced
163
Closed
86
Calls
$17.5M
Puts
$30.2M
Net Calls
-$12.7M
Net Calls Change
-$46.8M

Top Buyers

1
BlackRock
1
BlackRock
New York
$1.36B
2
B
2
Braidwell
Connecticut
$77.6M
3
AC
3
Armistice Capital
New York
$161M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$43.7M
5
Primecap Management
5
Primecap Management
California
$37.6M

Top Sellers

1
APM
1
Avidity Partners Management
Texas
$82.6M
2
Invesco
2
Invesco
Georgia
$58.3M
3
1832 Asset Management
3
1832 Asset Management
Ontario, Canada
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$3.3M
5
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$202M
Name Holding Trade Value Shares
Change 		Shares
Change %
PAMS
26
Pictet Asset Management (Switzerland)
Switzerland
$73.3M +$14.5M +142,767 +25%
Franklin Resources
27
Franklin Resources
California
$71.9M +$1.69M +16,672 +2%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$68.7M -$4.44M -43,900 -6%
First Trust Advisors
29
First Trust Advisors
Illinois
$68.2M +$30.2K +298 +0%
Man Group
30
Man Group
United Kingdom
$64.7M -$37.7M -315,970 Closed
Los Angeles Capital Management
31
Los Angeles Capital Management
California
$64.3M -$13M -128,847 -17%
BNP Paribas Asset Management
32
BNP Paribas Asset Management
France
$62M +$6.2M +61,297 +11%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$61.1M -$2.81M -27,808 -4%
Charles Schwab
34
Charles Schwab
California
$59.2M +$1.86M +18,353 +3%
GKIM
35
GW&K Investment Management
Massachusetts
$58.8M +$633K +6,255 +1%
Invesco
36
Invesco
Georgia
$58.3M -$86.1M -851,005 -60%
UBS AM
37
UBS AM
Illinois
$57.6M +$2.66M +26,266 +5%
Millennium Management
38
Millennium Management
New York
$57.5M -$27.5M -272,065 -32%
Bank of America
39
Bank of America
North Carolina
$55.6M -$5.05M -49,851 -8%
Ameriprise
40
Ameriprise
Minnesota
$55.2M -$5.85M -57,776 -10%
Legal & General Group
41
Legal & General Group
United Kingdom
$50M +$273K +2,696 +0.5%
O
42
OrbiMed
New York
$49.5M -$20.1M -198,700 -29%
Citadel Advisors
43
Citadel Advisors
Florida
$48M +$29.2M +288,824 +156%
Jacobs Levy Equity Management
44
Jacobs Levy Equity Management
New Jersey
$43.7M +$37.2M +367,229 +573%
WP
45
Woodline Partners
California
$40.4M +$9.14M +90,283 +29%
Principal Financial Group
46
Principal Financial Group
Iowa
$39.2M -$1.32M -13,082 -3%
CS
47
Candriam SCA
Luxembourg
$38.9M +$13.8M +148,008 +55%
Swiss National Bank
48
Swiss National Bank
Switzerland
$38.5M -$830K -8,200 -2%
Primecap Management
49
Primecap Management
California
$37.6M +$37.1M +366,640 +7,189%
Two Sigma Investments
50
Two Sigma Investments
New York
$37.5M -$20.3M -200,943 -35%
1
2
3 4 5